STOCK TITAN

If You Invested in Global Hemp Group Inc (GBHPF)

Healthcare · Drug Manufacturers - Specialty & Generic · OTC Link
Looking for the live price? See the GBHPF quote & overview
$1,000 invested 1 Year Ago
$6
-99.4% total -99.5% CAGR
Bought on Jul 8, 2025 at $0.02
$1,000 invested 5 Years Ago
$3
-99.7% total -69.3% CAGR
Bought on Jul 7, 2021 at $0.04

What $1,000 or $10,000 in GBHPF Would Be Worth Today

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Jul 8, 2015
$1,000 $6 -99% $3 -100% $14 -99% $7 -99%
$10,000 $61 -99% $28 -100% $143 -99% $70 -99%

Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for GBHPF

$1,000 Investment Over Time

GBHPF vs S&P 500

Year-by-Year Returns

GBHPF annual performance
Year Start Price End Price Annual Return Cumulative
2017 $0.03 $0.24 +774.3% +774.3%
2018 $0.27 $0.10 -63.0% +257.1%
2019 $0.10 $0.02 -81.9% -37.5%
2020 $0.02 $0.02 -4.0% -31.1%
2021 $0.02 $0.36 +1500.0% +1185.7%
2022 $0.34 $0.01 -96.8% -61.4%
2023 $0.01 $0.02 +57.4% -39.3%
2024 $0.06 $0.01 -82.6% -64.3%
2025 $0.01 $0.01 +11.0% -60.4%
2026 $0.01 $0.00 -98.0% -99.6%

About Global Hemp Group Inc

Healthcare · OTC Link

Global Hemp Group Inc. (OTC Pink: GBHPF), also listed on the Canadian Securities Exchange under the symbol GHG and on the Frankfurt exchange under GHG0 or GHG, is a hemp-focused company that has described a multi-phased strategy around industrial hemp and related health and wellness applications. According to multiple company news releases, Global Hemp Group has pursued projects that span industrial hemp cultivation, hemp-based construction materials, sustainable bio-energy applications, and biopharma-related intellectual property.

The company has repeatedly stated that it is headquartered in Vancouver, British Columbia, and has been involved in hemp cultivation operations in the state of Oregon. Earlier company disclosures describe a first phase centered on hemp cultivation with the objective of extracting cannabinoids, including CBG and CBD, and participating in the smokable CBG flower market. This cultivation activity has been positioned as a way to generate near-term revenue and support the development of subsequent phases focused on value-added industrial hemp products.

Industrial Hemp and Green Industrial Segment

Global Hemp Group reports that one of its key business segments is Industrial Hemp. In more recent corporate updates, the company describes this division as focusing on the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, with an emphasis on contributing to a carbon-negative footprint. Earlier news releases also reference a strategy to utilize the entire hemp plant, including hurd and fiber, to create value-added products within a centralized Hemp Agro-Industrial Zone (HAIZ) concept.

The company has announced an Exclusive Strategic Partnership to create a Sustainable Economic Zone in northwest Colorado with Western Sierra Resource Corporation. This project is described as a vertically integrated initiative that would generate multiple revenue streams from hemp cultivation, primary processing, and sustainable construction. Within this framework, Global Hemp Group has highlighted plans to focus cultivation on hurd and fiber, process these into building materials, and use those materials in the construction of affordable, environmentally oriented housing.

In addition, Global Hemp Group has entered into a Commercialization Agreement with the developer of a next generation 3D house printing technology. The company characterizes this as an expansion of its green industrial business segment, which has been focused on environmental uses of hemp for construction and sustainable bio-energy. The 3D house printing initiative is presented as a way to align hemp-based materials with emerging construction methods that aim to reduce resource use and enable more flexible housing designs.

Health & Wellness (Biopharma) Division

The second major business segment described by Global Hemp Group is its Health and Wellness (Biopharma) division. Company disclosures state that this division is focused on acquiring exclusive licensing of patents and intellectual property. Global Hemp Group reports that it has acquired exclusive rights to key patents and IP from Apollon Formularies plc, a UK-based international pharmaceutical company whose formulations and patents specialize in developing cancer treatments from natural biologics, including cannabinoids and functional mushrooms.

The company has also announced a Letter of Intent with B-Organic R&D Corp. relating to the use of Bioactive Lipid Agents (BLA) technology with cannabinoids, terpenes, flavonoids and mushroom extracts. According to Global Hemp Group, this BLA technology is intended to enhance the solubility and bioavailability of various poorly soluble pharmaceutical ingredients. The company describes these alliances as forming a basis for the potential commercialization of independently pre-clinically tested formulations in the commercial biopharma sector.

Research and Development Activities

Global Hemp Group emphasizes the role of its Research and Development Division, led by Prof. Víctor M. Castaño, Ph.D., a figure the company describes as a prominent leader in applied science and technology from the National Autonomous University of Mexico. The R&D Division is presented as central to the company’s broader strategy to leverage growing opportunities in the industrial hemp sector and related applications.

Company communications outline several initial R&D focus areas. These include the development of environmentally friendly construction materials derived from natural sources and agricultural byproducts, with the goal of producing materials that could replace traditional wood-based boards while offering specific mechanical and thermal characteristics. Global Hemp Group has also described work on nanofertilizers using nanotechnology, such as graphene and metal oxide nanoparticles, as an alternative approach to conventional chemical fertilizers, and research into enhanced extraction methods for essential oils and cannabinoids using enzymes and microfauna.

In connection with its construction-focused initiatives, the company has highlighted R&D on environmentally friendly cement formulations that could be used in 3D house printers, as well as research on incorporating hemp fiber into printing mixtures. The company notes that Prof. Castaño has assembled a team of Ph.D. candidates to assist in these research efforts.

Strategic Projects and Partnerships

Global Hemp Group has announced several projects intended to support its industrial hemp strategy. The company has described its Colorado Hemp Agro-Industrial Zone (HAIZ) concept as a centralized area adjacent to farming operations where hemp can be processed into value-added products, particularly building materials, and then used in the fabrication of affordable housing. The HAIZ initiative is associated with the broader Sustainable Economic Zone project in northwest Colorado, in partnership with Western Sierra Resource Corporation.

The company has also reported on its acquisition of the remaining 50% interest in the Scio, Oregon hemp project, resulting in full ownership of a 109-acre farm and the associated operating company. Earlier disclosures position this project as part of the company’s first-phase strategy focused on hemp cultivation for cannabinoid extraction and the smokable CBG flower market.

In the construction space, Global Hemp Group has announced the addition of a master hemp builder, Gabriel Gauthier, to advise on hemp building materials and hemp construction applications, particularly in relation to the Colorado HAIZ project. The company presents this expertise as supporting its goal of integrating hemp-based materials into real estate and housing initiatives.

Corporate Developments and Financing

Global Hemp Group has engaged in multiple financings and corporate transactions, including rights offerings, private placements, debt settlements, and options to acquire additional businesses. For example, the company has announced non-brokered private placements of units consisting of common shares and warrants, with proceeds earmarked for general working capital or specific operational and research purposes.

The company has also disclosed an Exclusive Option Agreement to acquire Serres Thériault (2021) Inc., a vertically integrated cannabis operator in New Brunswick. This option covers a cannabis compound with multiple buildings, licenses for cannabis micro processing, packaging and sales, greenhouse facilities, retail outlets, intellectual property, and partnerships related to hemp production and cannabis research. The transaction terms include share issuances, cash payments, a non-convertible note, and the potential assumption of STI’s debts and liabilities, subject to the option being exercised.

In a later update, Global Hemp Group reported that the British Columbia Securities Commission issued a failure-to-file cease trade order against the company for not filing certain continuous disclosure documents within prescribed timeframes. The company has applied for a partial revocation order to permit a proposed non-brokered private placement and has indicated that proceeds from such financing would be used to address outstanding filings, professional fees, operational commitments, and operating expenses. The company has stated its intention to seek a full revocation of the cease trade order and reinstatement of trading on the Canadian Securities Exchange after required filings are made, but has also noted that regulatory approvals are not guaranteed.

Business Focus and Sector Context

Across its disclosures, Global Hemp Group consistently describes itself as pursuing opportunities in industrial hemp and related health and wellness applications. Its industrial hemp activities center on environmental uses of hemp in construction and sustainable bio-energy, while its biopharma-focused Health and Wellness division is oriented around licensing and developing IP related to natural biologics, cannabinoids, and functional mushrooms.

The company’s projects and partnerships, including hemp cultivation in Oregon, the Colorado HAIZ concept, 3D house printing collaborations, and optioned cannabis operations in New Brunswick, are presented as ways to integrate hemp into construction, energy, and health-related markets. The R&D Division is positioned as a key driver for developing intellectual property that could be applied within the company’s projects and potentially beyond.

Market Cap
$0.0B
Current Price
$0.00
View full GBHPF overview

Frequently Asked Questions

Global Hemp Group Inc investment returns

How much would $1,000 invested in Global Hemp Group Inc be worth today?

If you invested $1,000 in Global Hemp Group Inc (GBHPF) 10 years ago on 2016-07-07, your investment would be worth $14 today, representing a -98.6% total return, growing at a compounded rate of -34.7% per year (CAGR).

Has Global Hemp Group Inc outperformed the S&P 500?

Over the past 10 years, GBHPF returned -98.6% compared to +258.6% for the S&P 500, underperforming the benchmark by 357.1 percentage points.

What is Global Hemp Group Inc's average annual return?

The compound annual growth rate (CAGR) of GBHPF over the past 10 years is -34.7%, growing at a compounded rate each year. Individual years vary significantly — GBHPF's best recent year was 2021 (+1500.0%) and worst was 2026 (-98.0%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.